Evidence map›Paper›PMID 37860661›Full record

ArticleChemical science2023

A heterologous expression platform in

Shu-Yi Lin, C Elizabeth Oakley, Cory B Jenkinson, Yi-Ming Chiang, Ching-Kuo Lee, Christopher G Jones, Paul M Seidler, Hosea M Nelson, Richard B Todd, Clay C C Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genetic Dereplication of MultipleJournal of natural products · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Transcription Factor Engineering inJournal of natural products · 2024
    Article
  13. Article
  14. Article
  15. A Timeline of Biosynthetic Gene Cluster Discovery inJournal of fungi (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Shu-Yi LinDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California Los Angeles CA 90089 USA clayw@usc.edu.ORCID https://orcid.org/0000-0001-7982-136X
C Elizabeth OakleyDepartment of Molecular Biosciences, University of Kansas 1200 Sunnyside Avenue Lawrence KS 66045 USA boakley@ku.edu.
Cory B JenkinsonDepartment of Molecular Biosciences, University of Kansas 1200 Sunnyside Avenue Lawrence KS 66045 USA boakley@ku.edu.
Yi-Ming ChiangDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California Los Angeles CA 90089 USA clayw@usc.edu.
Ching-Kuo LeeSchool of Pharmacy, College of Pharmacy, Taipei Medical University Taipei 11031 Taiwan.ORCID https://orcid.org/0000-0003-2827-396X
Christopher G JonesThe Arnold and Mabel Beckman Laboratory of Chemical Synthesis, Division of Chemistry and Chemical Engineering, California Institute of Technology Pasadena California 91125 USA.
Paul M SeidlerDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California Los Angeles CA 90089 USA clayw@usc.edu.
Hosea M NelsonThe Arnold and Mabel Beckman Laboratory of Chemical Synthesis, Division of Chemistry and Chemical Engineering, California Institute of Technology Pasadena California 91125 USA.
Richard B ToddDepartment of Plant Pathology, Kansas State University Manhattan KS 66506 USA.ORCID https://orcid.org/0000-0002-3494-948X
Clay C C WangDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California Los Angeles CA 90089 USA clayw@usc.edu.ORCID https://orcid.org/0000-0003-2955-7569
Berl R OakleyDepartment of Molecular Biosciences, University of Kansas 1200 Sunnyside Avenue Lawrence KS 66045 USA boakley@ku.edu.ORCID https://orcid.org/0000-0002-3046-8240
University of Southern California · USUniversity of Kansas · USCalifornia Institute of Technology · USKansas State University · USTaipei Medical University · TW

Funding

Resistance-gene-guided genome mining for novel antifungal compoundsR21AI156320 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI OAKLEY, BERL RAY · 2021 to 2022
$437k
NIAID NIH HHS R21 AI156320
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37860661
PMCPMC10583710
OpenAlexW4382140147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.